Mixed Epithelial Mesenchymal TumorsOpen image in new window

  • Jean Noel Buy
  • Michel Ghossain


Adeno fi broma = adeno (benign epithelial component) + fibroma (benign mesenchymal component)


Endometrial Carcinoma Uterine Cavity Stromal Component Cystic Space Endometrial Stromal Sarcoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Lee HK et al (1998) Uterine adenofibroma and adenosarcoma: CT and MR findings. J Comput Assist Tomogr 22(2):314–316PubMedCrossRefGoogle Scholar
  2. 2.
    Clement PB, Scully RE (1974) Mullerian adenosarcoma of the uterus. A clinicopathologic analysis of ten cases of a distinctive type of mullerian mixed tumor. Cancer 34(4):1138–1149PubMedCrossRefGoogle Scholar
  3. 3.
    Clement PB, Scully RE (1990) Mullerian adenosarcoma of the uterus: a clinicopathologic analysis of 100 cases with a review of the literature. Hum Pathol 21(4):363–381PubMedCrossRefGoogle Scholar
  4. 4.
    Kaku T et al (1992) Adenosarcoma of the uterus: a Gynecologic Oncology Group clinicopathologic study of 31 cases. Int J Gynecol Pathol 11(2):75–88PubMedCrossRefGoogle Scholar
  5. 5.
    Chourmouzi D et al (2003) Sonography and MRI of tamoxifen-associated mullerian adenosarcoma of the uterus. AJR Am J Roentgenol 181(6):1673–1675PubMedCrossRefGoogle Scholar
  6. 6.
    Harlow BL, Weiss NS, Lofton S (1986) The epidemiology of sarcomas of the uterus. J Natl Cancer Inst 76(3):399–402PubMedGoogle Scholar
  7. 7.
    Zaloudek C (2002) Mesenchymal tumors of the uterus. In: Blaustein’s pathology of the female genital tract. Springer, New York, pp 561–615Google Scholar
  8. 8.
    Silverberg SG et al (1990) Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases. Int J Gynecol Pathol 9(1):1–19PubMedCrossRefGoogle Scholar
  9. 9.
    Teo SY et al (2008) Primary malignant mixed mullerian tumor of the uterus: findings on sonography, CT, and gadolinium-enhanced MRI. AJR Am J Roentgenol 191(1):278–283PubMedCrossRefGoogle Scholar
  10. 10.
    Bharwani N et al (2010) MRI appearances of uterine malignant mixed ­mullerian tumors. AJR Am J Roentgenol 195(5):1268–1275PubMedCrossRefGoogle Scholar
  11. 11.
    Ohguri T et al (2002) MRI findings including gadolinium-enhanced dynamic studies of malignant, mixed mesodermal tumors of the uterus: differentiation from endometrial carcinomas. Eur Radiol 12(11):2737–2742PubMedGoogle Scholar
  12. 12.
    Namimoto T et al (2009) Role of diffusion-weighted imaging in the diagnosis of gynecological diseases. Eur Radiol 19(3):745–760PubMedCrossRefGoogle Scholar
  13. 13.
    Tanaka YO et al (2008) Carcinosarcoma of the uterus: MR findings. J Magn Reson Imaging 28(2):434–439PubMedCrossRefGoogle Scholar
  14. 14.
    Shapeero LG, Hricak H (1989) Mixed mullerian sarcoma of the uterus: MR imaging findings. AJR Am J Roentgenol 153(2):317–319PubMedCrossRefGoogle Scholar
  15. 15.
    Sahdev A et al (2001) MR imaging of uterine sarcomas. AJR Am J Roentgenol 177(6):1307–1311PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Jean Noel Buy
    • 1
  • Michel Ghossain
    • 2
  1. 1.Service RadiologieHopital Hotel-DieuParisFrance
  2. 2.Department of RadiologyHotel Dieu de FranceBeirutLebanon

Personalised recommendations